Autres

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Autres

17. Août 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3804


	Articles 1 - 20 / 76069

	Association of non-invasive liver-related scores with cardiovascular disease and a four-domain cardiovascular-renal-hepatic-metabolic phenotype in patients with type 2 diabetes mellitus and MASLD. Endocrine Stefanaki K, Karagiannakis DS, Manolakopoulou M, Magkou S, Georgiopoulos G, Liontos M, Vryonidou A, Peppa M, Kassi E, Psaltopoulou T, Paschou SA. PMID: 42603229 [PubMed - indexed for MEDLINE]
	Clinical and biochemical phenotypes of Lean MAFLD: machine learning-based biomarker identification and statistical association analysis in a cross-sectional study. Front Public Health Zhang H, Ji Y, Chen G, Tian Z. PMID: 42602026 [PubMed - indexed for MEDLINE]
	Risk factors for antipsychotic- and antidepressant-associated liver function abnormalities: A retrospective unmatched case-control study. Medicine (Baltimore) Zhu J, Zhou Q, Xiu Y. PMID: 42601736 [PubMed - indexed for MEDLINE]
	THE POTENTIAL HEPATOPROTECTIVE EFFECT OF PALMITOLEIC ACID AGAINST KETAMINE-INDUCED LIVER INJURY IN RATS: OXIDATIVE, INFLAMMATORY, AND HISTOPATHOLOGICAL EVALUATION. Georgian Med News Rafeeq F, Al-Thanoon Z. PMID: 42600605 [PubMed - indexed for MEDLINE]
	The LKB1-AMPK pathway in NAFLD: molecular mechanisms and therapeutic implications. J Physiol Biochem Goleij P, Tabari MAK, Naser Y, Alataa R, Osman MAM, Rezaee A, Aschner M, Ahmed ARD, Safrah MA, Khan H. PMID: 42599615 [PubMed - indexed for MEDLINE]
	Risk stratification of MASLD/MASH in type 2 diabetes: a pragmatic endocrinology outpatient pathway. Front Endocrinol (Lausanne) Cai Y, Zeng F, Liu C. PMID: 42597408 [PubMed - indexed for MEDLINE]
	Open, prospective, randomised, multicentre trial on quality assessment of declined liver grafts by normothermic ex situ machine perfusion for decreasing time to transplantation (ExTra trial): a study protocol. BMJ Open Moosburner S MHBA, Gassner JMGV, Sauer IM, Mandac M, Modest DP, Zocholl D, Stegherr R, Patel MS, Wendon J, Roderburg C, Selzner M, Pascher A, Fehrenbach U, Pratschke J, Raschzok N. PMID: 42595371 [PubMed - indexed for MEDLINE]
	The impact of short-term reduction in hepatic triglycerides on vascular health in adults with or at risk of metabolic dysfunction-associated steatotic liver disease. PLoS One Wang T, Gallagher I, Park J, Li Y, Caillaud M, Alhalimi TA, Chen LS, McLaurin NN, Knight-Scott J, Browning JD, Haley AP, Tanaka H. PMID: 42594065 [PubMed - indexed for MEDLINE]
	[Drug-induced liver injury (DILI)]. Praxis (Bern 1994) Zingg M, Greber R, Faleschini G, Hari R. PMID: 42591036 [PubMed - indexed for MEDLINE]
	Systemic Ammonia Toxicity: An Underestimated Driver of Cerebral Energy Crisis in Hepatic Encephalopathy. Int J Mol Sci Tikhonova L, Maevsky E, Montoliu C, Kosenko E. PMID: 42589396 [PubMed - indexed for MEDLINE]
	Computational Prediction of Hesperetin Modulatory Targets in Dibutyl Phthalate-Associated Steatotic Liver Injury: An Integrated Network Toxicology, Molecular Docking, and AOP-Based Study. Nutrients Zhou S, Li S, Zhao Y, Shi H, Zhao Y. PMID: 42588199 [PubMed - indexed for MEDLINE]
	Gut-Liver Axis Dysfunction in Alcohol-Associated Liver Disease and the Potential Role of Sheep Yogurt: A Scoping Review and Mechanistic Framework. Nutrients Wu Y, Zhao Y, Yao W, Yang Y, Bai H, Bao S, Li X, Song Y. PMID: 42588172 [PubMed - indexed for MEDLINE]
	The MASLD-Cardio-Oncology Triangle: Dietary Patterns, Metabolic Remodelling and Implications for Cancer Therapy Tolerance. Nutrients La Rocca F, Privitera G, Geraci C, Morello V, Geraci G, Paternò V, Santoro C, Esposito R. PMID: 42588152 [PubMed - indexed for MEDLINE]
	MASLD and Pancreatic Diseases: From Shared Mechanisms to Clinical Implications and Future Directions. Nutrients Rivera-Esteban J, Agudo B, Patrizi B, Manzur A, de la Iglesia D, Valverde V, García Ferris N, Esteban C, Santos E, Pons F, Hernández-Conde M, Abad J, González-Haba M, Calleja JL. PMID: 42588103 [PubMed - indexed for MEDLINE]
	Effect of Tomato Consumption on Liver Steatosis in MASLD: A Randomized Controlled Trial (POMOSANO Study). Nutrients Tatoli R, Donghia R, Carella N, Cerabino N, Di Chito M, Zappimbulso M, Pesole PL, Stabile D, Ferro A, Pascale G, Shahini E, Pavone F, Fontana L, Giannelli G. PMID: 42588099 [PubMed - indexed for MEDLINE]
	Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease. Cells Cruz AJL, Yuan L. PMID: 42587786 [PubMed - indexed for MEDLINE]
	Effect of high dose N-acetyl cysteine supplementation on markers of oxidative stress and insulin resistance in non-diabetic patients with metabolic dysfunction associated steatotic liver disease: a randomized controlled trial. BMC Gastroenterol Ramadan AM, El-Wakeel LM, Adel A, Abdel-Wahab M, Fahmy SF. PMID: 42587287 [PubMed - indexed for MEDLINE]
	Regulation of hepatic PNPLA3 gene expression by aerobic exercise and echium officinalis in a rat model of non-alcoholic fatty liver disease. Mol Biol Rep Nameni F, Gholamalipour Z. PMID: 42584790 [PubMed - indexed for MEDLINE]
	Metabolic Dysfunction-Associated Steatotic Liver Disease and Risk of Depressive Symptoms in Older Adults. Int J Geriatr Psychiatry Nasr Azadani M, Davoodian N, Berk M, Clayton-Chubb D, Forbes M, Ganjali S, Kemp W, Woods RL, Lotfaliany M, McNeil JJ, Pasco JA, Roberts SK, Mohebbi M. PMID: 42584001 [PubMed - indexed for MEDLINE]
	Association of serum acetaminophen levels with hepatorenal toxicity: A prospective observational study in Tripura, India. Indian J Pharmacol Ray D, Goswami B, Nath S, Saha P, Sengupta S. PMID: 42583983 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76069

Page 1 de 3804



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité